ARTICLE ABSTRACT
Long-term follow-up of patients with metastatic melanoma who received adoptive immunotherapy with autologous tumor infiltrating lymphocytes shows that patients who attained complete remission had durable responses, with 19 of 20 such patients remaining in remission from 3 to 7 years or more. Clin Cancer Res; 17(13); 4189–91. ©2011 AACR.
